In December 2025, the FDA approved Novo Nordisk's oral Wegovy, the first GLP-1 pill for obesity
The study covered individuals who began treatment between the drugs launch in Denmark (December 1st, 2022) and October 1st, 2023
To kill the weeds around my house, I said that I was going to get some high-octane vinegar at 45% purity and that stuff worked
Large-scale human studies and meta-analyses have largely been reassuring, showing no clear evidence of a significant increase in MTC risk for the general population
Studies using single oral doses of metformin hydrochloride tablets 500 mg to 1500 mg, and 850 mg to 2550 mg, indicate that there is a lack of dose proportionality with increasing doses, which is due to decreased absorption rather than an alteration in elimination